Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

被引：0
|
作者：
Lavin, V. [1 ]
Whitehurst, P. [2 ]
Harris, C. [2 ]
Goldstraw, R. [2 ]
Bayman, N. [1 ]
Chan, C. [1 ]
Coote, J. [1 ]
Harris, M. [1 ]
Pemberton, L. [1 ]
Sheikh, H. [1 ]
Woolf, D. [1 ]
Faivre-Finn, C. [1 ]
机构：
[1] Christie Hosp NHS Fdn Trust, Clin Oncol, BX, Manchester, Lancs, England
[2] Christie Hosp NHS Fdn Trust, Med Phys, BX, Manchester, Lancs, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [41] Standard Conventional Lobectomy vs Stereotactic Body Radiotherapy in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC) - A Review
    Balakrishnan, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1007 - S1008
  • [42] Stereotactic ablative body radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre results of the first year of treatment at Birmingham
    Stevenson, R.
    Price, L.
    Webster, G.
    Brennan, M.
    Stange, D.
    Wingate, E.
    Biard, K.
    Ghafoor, Q.
    LUNG CANCER, 2015, 87 : S47 - S47
  • [43] Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data
    Rusthoven, Chad G.
    Kavanagh, Brian D.
    Karam, Sana D.
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (11)
  • [44] Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
    Kim, Min-Jeong
    Yeo, Seung-Gu
    Kim, Eun Seok
    Min, Chul Kee
    Sean, Pyung
    ONCOLOGY LETTERS, 2013, 5 (03) : 840 - 844
  • [45] Hypofractionated Radiotherapy Regimens for Early Stage Non-Small Cell Lung Cancer
    Liu, F.
    Munley, M.
    MEDICAL PHYSICS, 2022, 49 (06) : E516 - E516
  • [46] Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): clinical outcome of 5 years of experience at the Oxford Cancer Centre
    Pascal, L.
    Bull, L.
    Ajzensztejn, D.
    Higgins, G.
    Stuart, R.
    Panakis, N.
    LUNG CANCER, 2018, 115 : S61 - S61
  • [47] Accelerated hypofractionated chemoradiation followed by stereotactic ablative radiotherapy boost for locally advanced, unresectable non-small cell lung cancer
    Weber, Urs M.
    Watson, Alexander S.
    Kavanagh, Brian D.
    Bunn, Paul A.
    TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02) : 676 - 678
  • [48] Nivolumab After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
    Chang, J. Y.
    Lin, S. H.
    Dong, W.
    Liao, Z.
    Gandhi, S.
    Chun, S. G.
    Gay, C. M.
    Zhang, J.
    Fossella, F. V.
    Blumenschein, G. R.
    Cascone, T.
    Le, X.
    Pozadzides, J. V.
    Tsao, A.
    Mehmet, A.
    Welsh, J. W.
    Verma, V.
    Wistuba, I. I.
    Lee, J.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S71 - S71
  • [49] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [50] Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) - a feasibility study
    Groom, N.
    Tsang, Y.
    Hatton, M.
    Hanna, G. G.
    Franks, K.
    Hardens, S.
    Mcdonald, F.
    Harrow, S.
    Faivre-Finn, C.
    LUNG CANCER, 2016, 91 : S69 - S70
12345